Non-Operative Management Approaches for Urinary Incontinence

Overseen By Elisar Khawam

Age: 18+

Sex: Female

Trial Phase: Academic

Sponsor: University Hospitals Cleveland Medical Center

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 1

Duration: 6-18 months

400 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

The overall goal is to improve diagnosis and non-operative management of urinary incontinence in women.

Who Is on the Research Team?

Adonis Hijaz, MD

Principal Investigator

University Hospitals Cleveland Medical Center

Goutham Rao, MD

Principal Investigator

University Hospitals Cleveland Medical Center

Are You a Good Fit for This Trial?

This trial is for women over 18 who are experiencing urinary incontinence and have visited the University Hospitals Cleveland Primary Care Institute. Participants should score at least 1 on a specific questionnaire about incontinence.

Inclusion Criteria

I am a woman who has seen a doctor at UH Cleveland's Primary Care Institute.

You score 1 or higher on a questionnaire about urinary incontinence.

Exclusion Criteria

Not applicable.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

1 visit (in-person)

Treatment

Participants are assigned to one of three groups: Usual Care plus Patient Educational Opportunities, Nurse Navigation, or Nurse Navigation and ChatBot, with ongoing management and education

6-18 months

Multiple visits (in-person and virtual)

Follow-up

Participants are monitored for adherence to therapy and improvement in symptoms, with data collection from medical records and questionnaires

6 months

Questionnaires and data collection

What Are the Treatments Tested in This Trial?

Interventions

• ChatBot
• Nurse Navigation
• Patient Education

Trial Overview The EMPOWER study aims to enhance the diagnosis and non-surgical treatment of urinary incontinence among women, using patient education, nurse-led guidance, and a ChatBot to provide support.

How Is the Trial Designed?

Group I: Arm 3 Experimental Treatment 3 Interventions

Patient Education + Nurse Navigation + ChatBot

Group II: Arm 2 Experimental Treatment 2 Interventions

Patient Education + Nurse Navigation

Group III: Arm 1 Experimental Treatment 1 Intervention

Patient Education

Who Is Running the Clinical Trial?

University Hospitals Cleveland Medical Center

Lead Sponsor

Trials

348

Recruited

394,000+

Adonis Hijaz, MD

Lead Sponsor

Trials

1

Recruited

400+